Concepedia

Publication | Open Access

A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease

19

Citations

9

References

2020

Year

Abstract

Ustekinumab in refractory CD results in significant clinical and endoscopic improvement and reinduction may be a viable option to recapture response.

References

YearCitations

Page 1